Moreover, FABP3 inhibitors have been shown to reduce αSyn oligomerization in a mouse model of PD induced by injection of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine14, 15 or αSyn preformed fibrils (PFFs).16, 17. This evidence concerns the gene FABP3 and Parkinson disease.